Abstract
Receptors for somatostatin were identified on mitogen-activated human peripheral blood lymphocytes (PBL) and human leukaemic cells in 87.5% of lymphoblastic leukaemia and in 12.5% of non-lymphocytic leukaemia, using a somatostatin radiobinding assay. The specific binding of 125I-somatostatin of these cells increased linearly with the cell numbers and was suppressed by non-iodinated somatostatin. We investigated the distribution of fluorescent somatostatin to mitogen-activated PBL by using a fluorescence-activated cell sorter (FACS). Over 95% of the cell populations bound fluorescent somatostatin and no distinct predilection was found among certain lymphocyte subpopulations and somatostatin receptor-positive cells. Scatchard analysis showed a single class (low affinity) of binding site on mitogen-activated PBL and two classes (high and low affinity) of specific binding sites on lymphoblastic leukaemia cells.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bhathena S. J., Louie J., Schechter G. P., Redman R. S., Wahl L., Recant L. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes. 1981 Feb;30(2):127–131. doi: 10.2337/diab.30.2.127. [DOI] [PubMed] [Google Scholar]
- Higuchi T., Kokubu T., Sikand G. S., Wada J. A., Friesen H. G. A study of somatostatin receptors in amygdaloid-kindled rat brain. Folia Psychiatr Neurol Jpn. 1985;39(3):305–308. doi: 10.1111/j.1440-1819.1985.tb02006.x. [DOI] [PubMed] [Google Scholar]
- Jakobs K. H., Aktories K., Schultz G. A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells. Nature. 1983 May 12;303(5913):177–178. doi: 10.1038/303177a0. [DOI] [PubMed] [Google Scholar]
- Johnson H. M., Torres B. A., Smith E. M., Dion L. D., Blalock J. E. Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol. 1984 Jan;132(1):246–250. [PubMed] [Google Scholar]
- Koch B. D., Schonbrunn A. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes. Endocrinology. 1984 May;114(5):1784–1790. doi: 10.1210/endo-114-5-1784. [DOI] [PubMed] [Google Scholar]
- Mascardo R. N., Barton R. W., Sherline P. Somatostatin has an antiproliferative effect on concanavalin A-activated rat thymocytes. Clin Immunol Immunopathol. 1984 Oct;33(1):131–138. doi: 10.1016/0090-1229(84)90299-x. [DOI] [PubMed] [Google Scholar]
- Matozaki T., Sakamoto C., Nagao M., Baba S. Phorbol ester or diacylglycerol modulates somatostatin binding to its receptors on rat pancreatic acinar cell membranes. J Biol Chem. 1986 Jan 25;261(3):1414–1420. [PubMed] [Google Scholar]
- Nakamura H., Koike T., Hiruma K., Sato T., Tomioka H., Yoshida S. Identification of lymphoid cell lines bearing receptors for somatostatin. Immunology. 1987 Dec;62(4):655–658. [PMC free article] [PubMed] [Google Scholar]
- Nordlind K., Mutt V. Modulating effect of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate. Int Arch Allergy Appl Immunol. 1986;81(4):368–370. doi: 10.1159/000234165. [DOI] [PubMed] [Google Scholar]
- O'Dorisio M. S., Hermina N. S., O'Dorisio T. M., Balcerzak S. P. Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. J Immunol. 1981 Dec;127(6):2551–2554. [PubMed] [Google Scholar]
- Organist M. L., Harvey J., McGillis J. P., Mitsuhashi M., Melera P., Payan D. G. Characterization of a monoclonal antibody against the lymphoblast substance P receptor. J Immunol. 1987 Nov 1;139(9):3050–3054. [PubMed] [Google Scholar]
- Payan D. G., Brewster D. R., Missirian-Bastian A., Goetzl E. J. Substance P recognition by a subset of human T lymphocytes. J Clin Invest. 1984 Oct;74(4):1532–1539. doi: 10.1172/JCI111567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Payan D. G., Hess C. A., Goetzl E. J. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol. 1984 Apr 1;84(2):433–438. doi: 10.1016/0008-8749(84)90117-5. [DOI] [PubMed] [Google Scholar]
- Reisine T. Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release. J Pharmacol Exp Ther. 1984 Apr;229(1):14–20. [PubMed] [Google Scholar]
- Reubi J. C., Landolt A. M. High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab. 1984 Dec;59(6):1148–1151. doi: 10.1210/jcem-59-6-1148. [DOI] [PubMed] [Google Scholar]
- Scicchitano R., Dazin P., Bienenstock J., Payan D. G., Stanisz A. M. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes. Brain Behav Immun. 1987 Jun;1(2):173–184. doi: 10.1016/0889-1591(87)90019-5. [DOI] [PubMed] [Google Scholar]
- Scicchitano R., Dazin P., Bienenstock J., Payan D. G., Stanisz A. M. The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. J Immunol. 1988 Aug 1;141(3):937–941. [PubMed] [Google Scholar]
- Srikant C. B., Patel Y. C. Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors. Endocrinology. 1985 May;116(5):1717–1723. doi: 10.1210/endo-116-5-1717. [DOI] [PubMed] [Google Scholar]
- Stanisz A. M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol. 1986 Jan;136(1):152–156. [PubMed] [Google Scholar]